Propranolol with hormone therapy for high-risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests if adding propranolol (a blood pressure medicine) to standard hormone therapy before prostate removal surgery helps treat high-risk prostate cancer. It is for patients who also have mild to moderate high blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 85 years old.
- You have high-risk or locally advanced prostate cancer that has not spread to distant organs.
- You have mild to moderate high blood pressure (systolic between 140 and 179 mmHg).
- You have not had any prior treatment for prostate cancer (like radiation, chemotherapy, or hormone therapy).
- You are able to take propranolol and do not have conditions like asthma, certain heart problems, or liver disease.
- You have not taken beta-blocker medications in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a team of doctors, nurses, and other specialists can help reduce the risk of heart problems in men with prostate cancer who are on hormone therapy (ADT). It focuses on providing extra support for heart health.
This trial studies giving hormone treatment and radiation before prostate surgery to treat high-risk, locally advanced prostate cancer. It aims to improve cancer control by shrinking or controlling the tumor before removing it.
This trial tests whether giving hormone therapy (androgen deprivation therapy) before surgery can improve outcomes for men with high-risk prostate cancer. You will receive a special PSMA PET/CT scan to see how the cancer responds.
This trial tests a new drug (BMS-986365) combined with another hormone therapy (degarelix) before radical prostatectomy for high-risk prostate cancer. The goal is to see if this combination helps lower cancer activity before surgery.
This trial tests adding propranolol (a heart medication) to standard chemotherapy before surgery for advanced high-grade serous ovarian cancer. The goal is to see if this combination helps shrink tumors more effectively.
This Phase 2 trial studies giving strong hormone-based treatment before prostate surgery to shrink and control high-risk, locally advanced prostate cancer. It may help improve surgical success and reduce cancer spread risk, but it requires careful health checks and prior-treatment limits.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.